Clinical Trial Update: Decatecholaminisation of Septic Shock With Dexmedetomidine and In-hospital Mortality [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating dexmedetomidine for decatecholaminisation in septic shock and its effect on in-hospital mortality; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Mansoura University | Conditions: Septic Shock, Sepsis | Phase 2 | Status: COMPLETED